BOD SCIENCE LIMITED logo
BOD
Consumer Discretionary Distribution & Retail

BOD Science

Short interest
0.00%
0.00 pp 30d
as of 24 Oct 2023
Reported shorts
1.7K
Shares on issue
177.339M

BOD Science (BOD) Short Interest

BOD Science (ASX:BOD) had 0.00% of shares reported as short positions as of 24 Oct 2023, representing 1,681 shares. BOD Science operates in the Consumer Discretionary Distribution & Retail industry. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Price & short interest

About BOD Science

Bod Science Limited (ASX:BOD) is a global life science healthcare company specializing in cannabis-centric products and solutions. The company is dedicated to innovating and transforming lives by delivering premium, proven, and trusted cannabinoid-based medications. It actively engages in clinical research, such as the CAN-REST study for insomnia, and provides comprehensive resources for accessing medicinal cannabis and informing both consumers and medical professionals.

Company profile →

BOD Science (ASX:BOD) has 0.00% of its shares on issue reported as short positions as of 24 Oct 2023, or about 1,681 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. BOD is classified in the Consumer Discretionary Distribution & Retail industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Company details

address

Level 1, 371 New South Head Road, SYDNEY, NSW, AUSTRALIA, 2028

Connect

More Consumer Discretionary Distribution & Retail Stocks

Other shorted stocks in this sector

Be the first to discuss BOD

Start a research thread or post the first pulse update